Florida International University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Miami FL United States (1965)

Organization Overview

First Clinical Trial
2001
NCT00149552
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Florida International University | Nicklaus Children's Hospital | Nicklaus Children's Hospital f/k/a Miami Children's Hospital | Professor, Florida International University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Afibrinogenemia (Phase 4)

Attention Deficit Disorder with Hyperactivity (Phase 4)

Blood Coagulation Disorders (Phase 4)

Brain Neoplasms (Phase 2)

Central Nervous System Neoplasms (Phase 3)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Ependymoma (Phase 2)

Glioma (Phase 2)

Hemostatic Disorders (Phase 4)

HIV Infections (Phase 3)

Medulloblastoma (Phase 2)

Mucopolysaccharidoses (Phase 3)

Mucopolysaccharidosis VII (Phase 3)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Nervous System Neoplasms (Phase 3)

Osteosarcoma (Phase 2)

Rhabdoid Tumor (Phase 2)

Sarcoma (Phase 2)

Sarcoma, Ewing (Phase 2)

Surgical Wound (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 23
  • # of Trial APIs: 29